Appreciate your enthusiasm. However, uplifting to NASDAQ is the cake not the cherry. GNBT absolutely tanked once it was delisted. How Joe got us to this point is incredible, but if there is no uplist, credibility, non-dilutive funding, the 1:4 NGIO dividend, and the 1:1 GNBT dividend go away and that’s just the obvious downside. GNBT needs to return to NASDAQ and the CNBC scroll.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links